Exploring Patient Pathways and Care Situations in Men With Erectile Dysfunction in Different PDE-5 Inhibitor Regulatory Settings. [PDF]
May U, Werthner Q, Weigmann H, Bauer C.
europepmc +1 more source
Synthesis and Pharmacological Evaluation of 6,7-Dihydro‑3<i>H</i>‑Oxazolo[3,4‑<i>a</i>]Pyrazine-5,8-Dione Compounds as Inhibitors of Phosphodiesterases 4 and 5. [PDF]
Helfstein DR +15 more
europepmc +1 more source
Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast. [PDF]
Barnawi G +4 more
europepmc +1 more source
Roflumilast Enhances Liraglutide's Atrial Natriuretic Peptide-Dependent Suppression of Adrenal Aldosterone Secretion. [PDF]
Hosseini A +9 more
europepmc +1 more source
Improved survival with phosphodiesterase-5 inhibitor use in men with male-predominant cancers: real-world large database study. [PDF]
Uralov D +10 more
europepmc +1 more source
Nitric oxide mediates ET-1-induced-inhibition of NPPB-sensitive Cl<sup>-</sup> currents in the early distal convoluted tubule of the mouse kidney. [PDF]
Hu L +6 more
europepmc +1 more source
Genetically Confirmed Localized Perianal Hailey-Hailey Disease Successfully Treated With Topical Difamilast: A Case Report. [PDF]
Maekawa M +4 more
europepmc +1 more source
Unveiling of phosphodiesterase-5 hot residues binding to xanthine derivatives for erectile dysfunction therapy: A computational drug repurposing approach. [PDF]
Elzupir AO, Almahmoud SAJ.
europepmc +1 more source
Chromosome 17q23.1-q23.2 deletion syndrome with severe pulmonary hypertension in neonates: two case reports and literature review. [PDF]
Wu X +5 more
europepmc +1 more source
Integrated Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulations Accelerate the Discovery of Novel PDE1 Inhibitors with Potential for the Treatment of Idiopathic Pulmonary Fibrosis. [PDF]
Cai XL +6 more
europepmc +1 more source

